Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 90 results found. Search for [ warning letter from USFDA ]

Results 1 to 21 of 90
PB Jayakumar
November 6, 2019
Most violations relate to rectifiable documentation, data maintenance, batch-wise consistent production quality, data on supply chain, stability issues, microbial contamination and quality checks


BusinessToday.In
New Delhi, November 4, 2019
SPARC Q2 results: Total income declined sharply by 70.49 per cent to Rs 19.45 crore during the second quarter as compared with Rs 65.92 crore in the year-ago period


BusinessToday.In
November 4, 2019
The USFDA warning letter will not affect the existing business of Cadila Healthcare in the US and the existing product supplies from the Moraiya facility will continue


BusinessToday.In
November 4, 2019
Cadila Healthcare share which opened at Rs 257 against previous close of Rs 255.30 hit an intra day high of Rs 260.6 (2.08%)


BusinessToday.In
November 4, 2019
HDFC Q2 results: The total revenue from operations increased by 10.35 per cent to Rs 10,478.33 crore in Q2FY20 from Rs 9,494.70 crore in Q2FY19


E Kumar Sharma
New Delhi, November 2, 2019
Dr Reddy's CFO Saumen Chakraborty attributed much of the challenges in the US market to price erosion and lower volumes


BusinessToday.In
October 11, 2019
Cipla share price has lost 2.51% in last 2 days. The US drug regulator carried out inspection from September 16-September 27 in the Goa unit of the firm.  It has subsequently issued form 483 comprising 38 pages which carries 12 observations for the Cipla's Goa facility.


BusinessToday.In
October 10, 2019
Torrent Pharma informed the bourses that it has received a warning letter dated 08-Oct-19 from the USFDA for its Indrad facility in Gujarat


PTI
October 7, 2019



BusinessToday.In
New Delhi, October 7, 2019
Weighed down by USFDA observations, share price of Aurobindo Pharma declined as much as 20.65 per cent to hit a 52-week low of Rs 450 on the BSE, after opening tad lower at Rs 560 against previous close level of Rs 567.15 on the BSE


PTI
October 7, 2019



PTI
July 21, 2019



BusinessToday.In
June 21, 2019
Aurobindo Pharma share has fallen 0.39% during the last one year and lost 17.31% since the beginning of this year.


E Kumar Sharma
New Delhi, June 10, 2019
What differentiates business leaders who display high octane stamina and productivity from lesser mortals who also work long hours


PTI
March 29, 2019



BusinessToday.In
New Delhi, March 26, 2019
In the last five trading session, shares of the company declined as much as 22.93 per cent on the BSE since March 19, which was Rs 843.35.


PTI
March 13, 2019



PTI
March 13, 2019



BusinessToday.In
March 8, 2019
Jubilant Life Sciences share price fell 4.67% to 747.30 level compared to the previous close of 783.90 on BSE. Jubilant Life Sciences share closed 1.96% or 15 points lower at 768.50 on BSE.


PTI
March 8, 2019



PAGES 1 OF 5  12345